Key result
ACE inhibitors are effective as first-line monotherapy or in combination regimens for the management of hypertension, particularly in patients with high coronary disease risk, diabetes, or heart failure.
This review highlights the pharmacotherapeutic nuances of ACE inhibitors, emphasizing their role as first-line therapy for hypertension and their synergistic effects in combination regimens.
Supports first-line ACE inhibitor use in indicated patients; confirms established role but leaves open optimal modern combinations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Domenic A. Sica (2005) conducted a review in Hypertension. Angiotensin-Converting Enzyme (ACE) Inhibitors was evaluated. ACE inhibitors are effective as first-line monotherapy or in combination regimens for the management of hypertension, particularly in patients with high coronary disease risk, diabetes, or heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: